Experimental Study of the Efficiency of Oxidized Dextran for Prevention of Influenza A/H5N1

Bulletin of Experimental Biology and Medicine

Volumn 158, Issue 1, 2014, Pages 112-114

  Shkurupy, V A ^a,b   Potapova, O V ^a   Sharkova, T V ^a   Troitskii, A V ^a   Gulyaeva, E P ^a   Bystrova, T N ^a   Shestopalov, A M ^a  

^a Research Institute of Experimental and Clinical Medicine   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

A goose Krasnoozerskoye 627 05; influenza A H5N1; outbred mice; oxidized dextran; prevention

Indexed keywords

DEXTRAN; OXIDIZED DEXTRAN; UNCLASSIFIED DRUG; ANTIVIRUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL INFECTION; EXPERIMENTAL STUDY; INFECTION PREVENTION; INFLUENZA A (H5N1); INFLUENZA A VIRUS (H5N1); LIFESPAN; MALE; MORTALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; ANIMAL; DRUG EFFECTS; DRUG SCREENING; INFLUENZA VIRUS A H5N1; ORTHOMYXOVIRIDAE INFECTIONS; OUTBRED STRAIN; OXIDATION REDUCTION REACTION; VIROLOGY;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIVIRAL AGENTS; DEXTRANS; DRUG EVALUATION, PRECLINICAL; INFLUENZA A VIRUS, H5N1 SUBTYPE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; OXIDATION-REDUCTION;

EID: 84922105428     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-014-2704-9     Document Type: Article

References (15)

1. V. A. Shkurupy, N. G. Luzgina, and A. V. Troitskii, Patent RF No. 2437664. A Means for Prevention of Avian Infl uenza in Mammals, Byull. No. 36, December 27, 2011.
2. V. A. Shkurupy, A. V. Troitsky, O. V. Potapova, and N. G. Luzgina, Patent EA200801376. A Method for Obtaining Dial dehyde Dextran Conjugate with Isoniazid, Byull. 2009–02.2009.04.28.
3. C. L. Cheung, J. M. Rayner, G. J. Smith, et al., J. Infect. Dis., 193, No. 12, 1626–1629 (2006).
4. N. A. Ilyushina, J. P. Seiler, J. E. Rehg, et al., PLoS Pathog., 6, No. 5, doi:10.1371/journal.ppat.1000933 (2010).
5. C. Korteweg and J. Gu, Am. J. Pathol., 172, No. 5, 1155–1170 (2008).
6. V. S. Medvedev, A. V. Troitsky, T. N. Bystrova, et al., Pharm. Chem., 46, No. 9, 573–577 (2012).
7. F. Pei, J. Zheng, Z. F. Gao, et al., Zhonghua Bing Li Xue Za Zhi, 34, No. 10, 656–660 (2005).
8. O. V. Potapova, V. A. Shkurupy, T. V. Sharkova, and A. M. Shestopalov, Bull. Exp. Biol. Med., 148, No. 6, 892–895 (2009).
9. T. V. Sharkova, O. V. Potapova, V. A. Shkurupy, et al., Bull. Exp. Biol. Med., 146, No. 2, 243–245 (2008).
10. A. M. Shestopalov, K. A. Sharshov, A. V. Zaykovskaya, et al., Bull. Exp. Biol. Med., 146, No. 3, 341–343 (2008).
11. V. A. Shkurupy, Tuberculous Granulomatosis, Cytophysiology and Address Therapy, Moscow (2007).
12. V. A. Shkurupy, S. A. Arkhipov, A. V. Troitsky, et al., Bull. Exp. Biol. Med., 148, No. 4, 710–712 (2009).
13. J. K. Taubenberger and D. M. Morens, Emerg. Infect. Dis., 12, No. 1, 15–22 (2006).
14. V. O. Tkachev, O. P. Kolesnikova, A. V. Troitskii, and V. A. Shkurupy, Bull. Exp. Biol. Med., 146, No. 1, 83–85 (2008).
15. R. J. Webby and R. G. Webster, Philos. Trans. R. Soc. Lond. B. Biol. Sci., 356, No. 1416, 1817–1828 (2001).